Market Place
Sourcing Support
All News #Library
Biotech
UCB strikes $1.15B deal for cell therapy biotech Neurona
17 Apr 2026 //
FIERCE BIOTECH
Neurona Therapeutics Unveils Long-Term NRTX-1001 Cell Therapy
08 Dec 2025 //
GLOBENEWSWIRE
EMA Grants PRIME Status to NRTX-1001 for Refractory Epilepsy
05 Nov 2025 //
GLOBENEWSWIRE
Neurona Expands NRTX-1001 Cell Therapy Study In MTLE Without MTS
07 Oct 2025 //
GLOBENEWSWIRE
Neurona Reports Successful Preclinical Interneuron Cell Therapy
11 Jul 2025 //
GLOBENEWSWIRE
Neurona doses first patient in NRTX-1001 trial for MTLE
18 Jun 2025 //
GLOBENEWSWIRE
Neurona Therapeutics Presents Positive Data from NRTX-1001 Trial
08 Apr 2025 //
GLOBENEWSWIRE
Neurona Therapeutics Raises $102M for NRTX-1001 Ph 3 Epilepsy Trial
03 Apr 2025 //
GLOBENEWSWIRE
Neurona Launches Ph 3 EPIC Study For NRTX-1001 In Epilepsy
20 Feb 2025 //
GLOBENEWSWIRE
Neurona Positive NRTX-1001 Data for Drug-Resistant Epilepsy
06 Dec 2024 //
GLOBENEWSWIRE
Neurona Gets $3.8M CIRM Grant For Neural Cell Therapy
10 Sep 2024 //
GLOBENEWSWIRE
Neurona: NRTX-1001 Epilepsy Data At AAN 2024
15 Apr 2024 //
GLOBENEWSWIRE
Neurona raises $120M to take epilepsy cell therapy to late-stage development
08 Feb 2024 //
ENDPTS
Neurona Presents One-Year Data on the First Patient Treated with NRTX-1001
15 Jun 2023 //
GLOBENEWSWIRE
Neurona’s brain stem cell therapy shows early efficacy in epilepsy
15 Jun 2023 //
CLINICAL TRIALS ARENA
Neurona Announce FDA Clearance of Expanded Criteria for PI/II Trial of NRTX-1001
14 Feb 2023 //
GLOBENEWSWIRE
Epilepsy and Alzheimer`s cell therapy biotech lays off 25% of staff
07 Feb 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.